AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19220383 — intervention group
Group type: COMPARATOR
Intervention: No leakage
Number of subjects: 390
Study 18332071 — intervention group
Group type: EXPERIMENTAL
Intervention: TPA-based antibiotic lock (ABL)
Number of subjects: 42
Study 18332071 — intervention group
Group type: COMPARATOR
Intervention: Heparin-based antibiotic lock (ABL)
Number of subjects: 42
Study 15976981 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 French 6 mm tip cryothermal catheter
Number of subjects: 94
Study 15976981 — intervention group
Group type: COMPARATOR
Intervention: 9 French 8 mm tip cryothermal catheter
Number of subjects: 94
Study 11930970 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 0
Study 11930970 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 10066655 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 91
Study 10066655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 7593876 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT)
Number of subjects: 156
Study 7593876 — intervention group
Group type: COMPARATOR
Intervention: Delayed-treatment control
Number of subjects: 156
Study 1961617 — intervention group
Group type: EXPERIMENTAL
Intervention: Iris iridectomies or iridotomies using a discission knife
Number of subjects: 1346
Study 1961617 — intervention group
Group type: COMPARATOR
Intervention: No iridectomy or large iris opening made with scissors
Number of subjects: 1346
Study 6160353 — intervention group
Group type: EXPERIMENTAL
Intervention: N-allyl-clonidine (ST 567) 40 mg, i.v.
Number of subjects: 18
Study 31374027 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH pulse therapy
Number of subjects: 220
Study 31374027 — intervention group
Group type: COMPARATOR
Intervention: HCG/HMG combined treatment
Number of subjects: 220
Study 29099829 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 13
Study 29099829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 25990940 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resistance and balance-jumping training (COMB)
Number of subjects: 145
Study 23113645 — intervention group
Group type: EXPERIMENTAL
Intervention: SST augmented with intraoperative mitomycin-C (MMC)
Number of subjects: 60
Study 23113645 — intervention group
Group type: COMPARATOR
Intervention: SST using Ologen implant
Number of subjects: 60
Study 21537938 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol intake
Number of subjects: 32
Study 21537938 — intervention group
Group type: COMPARATOR
Intervention: Placebo intake
Number of subjects: 32
Study 19027977 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglitol 150 mg/day
Number of subjects: 40
Study 19027977 — intervention group
Group type: COMPARATOR
Intervention: Mitiglinide 30 mg/day
Number of subjects: 40
Study 16269646 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant factor VIIa (rFVIIa) administered intravenously within 4 hours of ICH onset
Number of subjects: 1018
Study 16269646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1018
Study 11975864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimicifugae racemosae rhizoma (40 mg/day)
Number of subjects: 72
Study 11975864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimicifugae racemosae rhizoma (39 mg)
Number of subjects: 72
Study 11975864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimicifugae racemosae rhizoma (127.3 mg)
Number of subjects: 72
Study 11975864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimicifugae racemosae rhizoma (higher dose)
Number of subjects: 72
Study 11975864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimicifugae racemosae rhizoma (all doses)
Number of subjects: 72
Study 10585169 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid ingestion during a 90 min intermittent exercise protocol
Number of subjects: 9
Study 10585169 — intervention group
Group type: COMPARATOR
Intervention: No fluid intake during a 90 min intermittent exercise protocol
Number of subjects: 9
Study 7852113 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose total body irradiation (STBI)
Number of subjects: 171
Study 7852113 — intervention group
Group type: COMPARATOR
Intervention: Fractionated total body irradiation (FTBI)
Number of subjects: 171
Study 2031813 — intervention group
Group type: EXPERIMENTAL
Intervention: Berman 11 Intubating Airway
Number of subjects: 75
Study 2031813 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue traction method of fibreoptic intubation
Number of subjects: 75
Study 2031813 — intervention group
Group type: COMPARATOR
Intervention: Macintosh intubation
Number of subjects: 75
Study 2031813 — intervention group
Group type: EXPERIMENTAL
Intervention: Both fibreoptic techniques
Number of subjects: 75
Study 2031813 — intervention group
Group type: EXPERIMENTAL
Intervention: Berman airway and tongue traction
Number of subjects: 75
Study 7346530 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg Slo-Phyllin Gyrocap
Number of subjects: 8
Study 7346530 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg Theo-dur tablet
Number of subjects: 8
Study 31287046 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) of praziquantel, given annually or twice over 4 years
Number of subjects: 5
Study 31287046 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based or community-wide MDA
Number of subjects: 5
Study 28674144 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook campaigns
Number of subjects: 1357
Study 28674144 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet and social media advertising
Number of subjects: 1357
Study 28674144 — intervention group
Group type: EXPERIMENTAL
Intervention: Network strategies
Number of subjects: 1357
Study 28674144 — intervention group
Group type: COMPARATOR
Intervention: Radio advertising
Number of subjects: 1357
Study 26474603 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized decision support system (CDSS) NHGDoc
Number of subjects: 229
Study 23706168 — intervention group
Group type: EXPERIMENTAL
Intervention: HR-HPV prevalence in Trento
Number of subjects: 46900
Study 23706168 — intervention group
Group type: EXPERIMENTAL
Intervention: HR-HPV prevalence in Ravenna
Number of subjects: 46900
Study 23706168 — intervention group
Group type: EXPERIMENTAL
Intervention: HR-HPV prevalence in 6 centres (Trento, Verona, Florence, Bologna, Imola, Viterbo)
Number of subjects: 46900
Study 23706168 — intervention group
Group type: EXPERIMENTAL
Intervention: HR-HPV prevalence in Padua
Number of subjects: 46900
Study 23706168 — intervention group
Group type: EXPERIMENTAL
Intervention: HR-HPV prevalence in Turin
Number of subjects: 46900
Study 21324992 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support intervention (standardised diabetes care system, recruitment and training of peer supporters, nine group meetings over two years)
Number of subjects: 395
Study 21324992 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support intervention
Number of subjects: 395
Study 21324992 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard diabetes care without peer support)
Number of subjects: 395
Study 18625625 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 49
Study 18625625 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vaccination)
Number of subjects: 49
Study 17313708 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume resistance exercise (HVRE) - four sets of eight exercises, twelve repetitions at 12 RM, energy expenditure 1 x 40 MJ
Number of subjects: 10
Study 17313708 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume resistance exercise (LVRE) - two sets of eight exercises, twelve repetitions at 12 RM, energy expenditure 0 x 76 MJ
Number of subjects: 10
Study 17313708 — intervention group
Group type: COMPARATOR
Intervention: Control - refrained from exercise
Number of subjects: 10
Study 15196107 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID (diclofenac)
Number of subjects: 51
Study 15196107 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid (oxycodone)
Number of subjects: 51
Study 15196107 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural (bupivacaine + fentanyl)
Number of subjects: 51
Study 11777713 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight phacoemulsification tip (0.9 mm diameter)
Number of subjects: 256
Study 11777713 — intervention group
Group type: EXPERIMENTAL
Intervention: Flared phacoemulsification tip (0.76 mm diameter, flaring to 1.02 mm)
Number of subjects: 256
Study 10530095 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Oral-B 3D Plaque Remover
Number of subjects: 114
Study 10530095 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 114
Study 7867825 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 10
Study 7867825 — intervention group
Group type: COMPARATOR
Intervention: Placebo (hypromellose)
Number of subjects: 10
Study 2673621 — intervention group
Group type: COMPARATOR
Intervention: 100 mg/day viqualine
Number of subjects: 29
Study 2673621 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day viqualine
Number of subjects: 29
Study 2673621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 2673621 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of viqualine
Number of subjects: 29
Study 10942 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1 or 2 mg)
Number of subjects: 12
Study 10942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31769377 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial-based cognitive therapy (TBCT)
Number of subjects: 76
Study 31769377 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral activation (BA)
Number of subjects: 76
Study 31769377 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 76
Study 31359374 — intervention group
Group type: EXPERIMENTAL
Intervention: Video education (personalized videos with specific grade, stage, and tumor subtype information)
Number of subjects: 28
Study 31359374 — intervention group
Group type: COMPARATOR
Intervention: Standard of care educational materials (control group)
Number of subjects: 28
Study 28046034 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent notifications
Number of subjects: 77
Study 28046034 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily notifications within pre-defined time frames
Number of subjects: 77
Study 28046034 — intervention group
Group type: COMPARATOR
Intervention: Occasional notifications within pre-defined time frames
Number of subjects: 77
Study 25753818 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 197
Study 25753818 — intervention group
Group type: COMPARATOR
Intervention: Expressive suppression
Number of subjects: 197
Study 25753818 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative urgency
Number of subjects: 197
Study 23877854 — intervention group
Group type: EXPERIMENTAL
Intervention: Stented valve
Number of subjects: 40
Study 23877854 — intervention group
Group type: COMPARATOR
Intervention: Stentless valve
Number of subjects: 40
Study 22105724 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sedation with intravenous propofol administered by anesthesiologist
Number of subjects: 50
Study 18725490 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with stenting
Number of subjects: 3051
Study 18725490 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 3051
Study 16227143 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 14
Study 16227143 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac after pre-treatment with bendroflumethiazide and enalapril
Number of subjects: 14
Study 11799940 — intervention group
Group type: EXPERIMENTAL
Intervention: Scintimammography for dense breasts
Number of subjects: 558
Study 11799940 — intervention group
Group type: EXPERIMENTAL
Intervention: Scintimammography for fatty breasts
Number of subjects: 558
Study 9813556 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion (5‐20 ng/kg/min)
Number of subjects: 10
Study 9813556 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine infusion (0.7‐2.8 micrograms/kg/min)
Number of subjects: 10
Study 7659203 — intervention group
Group type: EXPERIMENTAL
Intervention: lormetazepam (1 mg)
Number of subjects: 16
Study 7659203 — intervention group
Group type: EXPERIMENTAL
Intervention: zopiclone (7.5 mg)
Number of subjects: 16
Study 7659203 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study 2802120 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg intravenously
Number of subjects: 10
Study 2802120 — intervention group
Group type: COMPARATOR
Intervention: No H2-receptor antagonist (control)
Number of subjects: 10
Study 184913 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative radiotherapy (group A, 73 patients)
Number of subjects: 195
Study 184913 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiotherapy only (group B, 64 patients)
Number of subjects: 195
Study 184913 — intervention group
Group type: EXPERIMENTAL
Intervention: Single course of actinomycin D (group I, 80 patients)
Number of subjects: 195
Study 184913 — intervention group
Group type: COMPARATOR
Intervention: Multiple courses of actinomycin D (group II, 80 patients)
Number of subjects: 195
Study 30503218 — intervention group
Group type: EXPERIMENTAL
Intervention: PACT plus Enhanced Usual Care (PACT+EUC)
Number of subjects: 24
Study 30503218 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 24
Study 28916164 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity motivational intervention (G1)
Number of subjects: 180
Study 28916164 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower intensity consultation, non-motivational group (G2)
Number of subjects: 180
Study 28916164 — intervention group
Group type: COMPARATOR
Intervention: Recommendations for weight loss and follow-up in Primary Care Clinic (G3)
Number of subjects: 180
Study 28002035 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplement for 12 weeks
Number of subjects: 117
Study 28002035 — intervention group
Group type: COMPARATOR
Intervention: Control group (no omega-3 supplement)
Number of subjects: 117
Study 24431097 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil
Number of subjects: 0
Study 23297557 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 480
Study 23297557 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhizhukuanzhong capsules (ZZKZC)
Number of subjects: 480
Study 23297557 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (Electroacupuncture + ZZKZC)
Number of subjects: 480
Study 23297557 — intervention group
Group type: COMPARATOR
Intervention: Control (5 mg mosapride three times daily and 20 mg pantoprazole twice daily)
Number of subjects: 480
Study 23297557 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life scores
Number of subjects: 480
Study 20377635 — intervention group
Group type: EXPERIMENTAL
Intervention: Coparenting alliance
Number of subjects: 0
Study 20377635 — intervention group
Group type: COMPARATOR
Intervention: Traditional indirect model
Number of subjects: 0
Study 20377635 — intervention group
Group type: COMPARATOR
Intervention: Alternative predictor model
Number of subjects: 0
Study 18538974 — intervention group
Group type: EXPERIMENTAL
Intervention: New transdermal fentanyl patch
Number of subjects: 220
Study 18538974 — intervention group
Group type: COMPARATOR
Intervention: Standard opioid treatment
Number of subjects: 220
Study 16255878 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive strategy
Number of subjects: 545
Study 16255878 — intervention group
Group type: COMPARATOR
Intervention: Early conservative strategy
Number of subjects: 545
Study 11738537 — intervention group
Group type: EXPERIMENTAL
Intervention: quetiapine 600 mg/day
Number of subjects: 58
Study 11738537 — intervention group
Group type: COMPARATOR
Intervention: haloperidol 12 mg/day
Number of subjects: 58
Study 9672340 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio and visual stimulation
Number of subjects: 37
Study 7876509 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 0
Study 7876509 — intervention group
Group type: COMPARATOR
Intervention: Oral therapy (control)
Number of subjects: 0
Study 2690165 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone therapy
Number of subjects: 0
Study 2690165 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study 2690165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 4730188 — intervention group
Group type: EXPERIMENTAL
Intervention: Watching violent television programmes
Number of subjects: 0
Study 4730188 — intervention group
Group type: EXPERIMENTAL
Intervention: Watching violent films
Number of subjects: 0
Study 31958993 — intervention group
Group type: EXPERIMENTAL
Intervention: Greenbrier Children's Health Opportunities Involving Coordinated Efforts in Schools intervention
Number of subjects: 4633
Study 31855077 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR)
Number of subjects: 80
Study 31855077 — intervention group
Group type: COMPARATOR
Intervention: Passive Recovery (PR)
Number of subjects: 80
Study 28611374 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycobacterium indicus pranii (MIP)
Number of subjects: 890
Study 28611374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 890
Study 25862299 — intervention group
Group type: EXPERIMENTAL
Intervention: DSJI (disposable-syringe jet injector)
Number of subjects: 96
Study 25862299 — intervention group
Group type: COMPARATOR
Intervention: NS (needle and syringe)
Number of subjects: 96
Study 25862299 — intervention group
Group type: COMPARATOR
Intervention: NS
Number of subjects: 96
Study 25862299 — intervention group
Group type: EXPERIMENTAL
Intervention: DSJI and NS
Number of subjects: 96
Study 24167166 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmedical prescription opiate use (NPOU)
Number of subjects: 2135
Study 24167166 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmedical prescription sedative use (NPSU)
Number of subjects: 2135
Study 24167166 — intervention group
Group type: EXPERIMENTAL
Intervention: Current home prescription for opioids
Number of subjects: 2135
Study 24167166 — intervention group
Group type: EXPERIMENTAL
Intervention: Current home prescription for sedatives
Number of subjects: 2135
Study 24167166 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving an intravenous opioid in the ED
Number of subjects: 2135
Study 24167166 — intervention group
Group type: EXPERIMENTAL
Intervention: Dating violence
Number of subjects: 2135
Study 24167166 — intervention group
Group type: EXPERIMENTAL
Intervention: Presenting to the ED for a noninjury complaint
Number of subjects: 2135
Study 24167166 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous ED visit in the past year
Number of subjects: 2135
Study 24167166 — intervention group
Group type: EXPERIMENTAL
Intervention: Other substance use, drinking and driving or riding with a drinking driver
Number of subjects: 2135
Study 21190903 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter readjustment after displacement
Number of subjects: 20
Study 21190903 — intervention group
Group type: COMPARATOR
Intervention: Initial catheter position without readjustment
Number of subjects: 20
Study 19101235 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (0.25 mg/day)
Number of subjects: 7788
Study 19101235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7788
Study 17544419 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 18
Study 17544419 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg)
Number of subjects: 18
Study 14534838 — intervention group
Group type: EXPERIMENTAL
Intervention: Free fat grafts (group A)
Number of subjects: 99
Study 14534838 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 99
Study 11568045 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial switch operation (ASO)
Number of subjects: 155
Study 9668931 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage of readiness to change at pretest
Number of subjects: 0
Study 9668931 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipated positive and negative outcomes of quitting, perceived self-efficacy, and smoking behavior
Number of subjects: 0
Study 9668931 — intervention group
Group type: COMPARATOR
Intervention: Number of cigarettes smoked a day, nicotine dependence score, and number of years smoked
Number of subjects: 0
Study 7816524 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystic fibrosis patients
Number of subjects: 25
Study 7816524 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study 28523953 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracranial Pressure (ICP) measured immediately after hemicraniectomy
Number of subjects: 25
Study 28523953 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracranial Pressure (ICP)
Number of subjects: 25
Study 28523953 — intervention group
Group type: EXPERIMENTAL
Intervention: Survival at 6 months
Number of subjects: 25
Study 28523953 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated ICP
Number of subjects: 25
Study 26501698 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert panel review
Number of subjects: 106
Study 26501698 — intervention group
Group type: COMPARATOR
Intervention: No expert panel review
Number of subjects: 106
Study 26501698 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert panel review with all experts or all except 1 voting for randomization
Number of subjects: 106
Study 26501698 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert panel review with 2 experts voting against randomization
Number of subjects: 106
Study 26501698 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert panel review with 3 or 4 experts voting against randomization
Number of subjects: 106
Study 25052178 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based vestibular rehabilitation (VR) intervention
Number of subjects: 262
Study 25052178 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 262